Literature DB >> 3221986

Epidemiology of infantile hydrocephalus in Sweden. Current aspects of the outcome in preterm infants.

E Fernell1, B Hagberg, G Hagberg, G Hult, L von Wendt.   

Abstract

The outcome in a population-based series of 61 Swedish preterm infants born in 1967-82 with infantile hydrocephalus (IH) was investigated. Sixteen (26%) died before the age of two years. The available information was updated when the 45 surviving children were at least four years and six months old. A structured follow-up examination was performed in the 13 children who had passed the age of six years. Among the 45 survivors, 47% had cerebral palsy, 51% mental retardation and 33% epilepsy. The overall outcome for preterm infants with IH was found to be poorer than that for fullterm ones. Prognostic factors correlating to a poor outcome were an obvious origin of IH (pre- or perinatal) and a gestational age of less than 28 weeks. It is concluded that handicapped IH children born very or extremely prematurely constitute a new, and to a large extent severely brain-damaged group that has entered the Swedish IH panorama since the end of the 1970s.

Entities:  

Mesh:

Year:  1988        PMID: 3221986     DOI: 10.1055/s-2008-1052418

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  3 in total

1.  Very long-term follow-up of cognitive function in adults treated in infancy for hydrocephalus.

Authors:  Barbro Lindquist; Eva-Karin Persson; Elisabeth Fernell; Paul Uvebrant
Journal:  Childs Nerv Syst       Date:  2010-10-23       Impact factor: 1.475

2.  Very long-term follow-up of adults treated in infancy for hydrocephalus.

Authors:  Eva-Karin Persson; Barbro Lindquist; Paul Uvebrant; Elisabeth Fernell
Journal:  Childs Nerv Syst       Date:  2011-06-24       Impact factor: 1.475

3.  The light-flash-evoked response as a possible indicator of increased intracranial pressure in hydrocephalus.

Authors:  A Sjöström; P Uvebrant; A Roos
Journal:  Childs Nerv Syst       Date:  1995-07       Impact factor: 1.475

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.